abstract |
The invention provides novel 2,3,6-substituted quinazolinones having the formula <IMAGE> Formula I wherein R6 is <IMAGE> and X, R, R1, R2, R3, R4 and R8 are described in the specification which have activity as angiotensin II (AII) antagonists. |